The Turin Prostate Cancer Prognostication study, launched this year thanks to a grant from the AIRC Foundation, has activated a website to present the research initiative and, in perspective, facilitate the dissemination of results and the sharing of protocols.

TPCP is a non-pharmacological retrospective cohort observational study whose objective is to respond to the need to improve the prognosis of prostate cancer, both in terms of identifying new prognostic markers and in terms of improving current prognostic models.

The study is part of a consolidated line of research initiated at the Department of Medical Sciences (DSM) of the University of Turin, the Piedmont CPO and the Structures of Pathological Anatomy and Urology of the AOU Città della Salute e della Scienza in Turin, in collaboration with the Karolinska Institutet.

To know more: